Develops inhaled medicines for respiratory diseases, focusing on novel treatments through clinical trials and FDA-approved development pathways.
Buy
Sign up to view historical trading trends and place an offer.
Sell
Understand share pricing, list anonymously, and benefit from transparent fees.
Overview
Pulmocide is a biopharmaceutical company specializing in developing inhaled medicines for serious respiratory diseases. Their lead product, opelconazole, is an investigational inhaled azole therapy currently undergoing Phase 3 clinical trials. The company has received several FDA designations, including orphan drug, Fast Track, and Qualified Infectious Disease Product (QIDP) status, to expedite opelconazole’s development and review.
Buy
Sign up to view historical trading trends and place an offer.
Sell
Understand share pricing, list anonymously, and benefit from transparent fees.
Pulmocide Management Team
Pulmocide Valuations & Financials
View real-time NPM data on Pulmocide stock including daily Pulmocide stock price estimates, valuation history, and historical share price information. Access Pulmocide financing rounds, secondary trade levels, cap table data, and private company comparable transactions. Use NPM's private company valuation database to track Pulmocide pricing across six independent market signals. Looking for private company due diligence data sources on Pulmocide? Get in touch to learn more.
Similar Companies
like Pulmocide
WaveFront Dynamics
Healthcare & Life Sciences
Develops advanced wavefront sensing devices and diagnostic tools to measure and enhance visual performance in eye care.
Robocath
Healthcare & Life Sciences
Develops and commercializes robotic solutions for treating cardiovascular diseases through precise, automated medical assistance.
Francis Medical
Healthcare & Life Sciences
Develops minimally invasive water vapor ablation technology to treat prostate, kidney, and bladder cancer with fewer side effects.
Simple HealthKit
Healthcare & Life Sciences
Delivers accessible, affordable diagnostics and follow-up care for sexual wellness, respiratory health, chronic conditions, and more.
NuEyes Technologies
Healthcare & Life Sciences
Engineers augmented reality smart glasses to enhance visual capabilities for low-vision patients.
Affinia Therapeutics
Healthcare & Life Sciences
Develops next-generation gene therapies by designing novel AAV capsids to improve targeting, safety, and efficacy for serious diseases.
DNA Nanobots
Healthcare & Life Sciences
Designs programmable biological structures to deliver targeted pharmaceutical payloads into cellular tissues.
Credo Health
Healthcare & Life Sciences
Delivers AI-powered pre-encounter risk analysis and clinical insights to help providers close care gaps and personalize patient care.
rzero
Healthcare & Life Sciences
Delivers AI-driven solutions that optimize HVAC efficiency and indoor air quality by automating building operations with real-time data.
FAQ
We have answers
Pulmocide stock does not trade on public stock exchanges. Pulmocide stock is considered a private security and you need to be an accredited investor to trade shares. To invest in Pulmocide stock you can either buy shares directly through the company or work with a secondary trading marketplace like Nasdaq Private Market.
Learn more about the secondary market for private company shares on the investors page.
Pulmocide Stock does not trade on public stock exchanges. In order to sell Pulmocide shares you need to work directly with the company or with a secondary trading marketplace like Nasdaq Private Market. NPM has more than a decade of experience helping sell shares on the private market to our network of institutional investors.
Learn more about NPM services for selling privately held stock on the Employee Shareholders page.
Read more about how to sell private company stock on the private secondary market:
Pulmocide does not have a publicly available stock price because it is privately held and not traded on public stock exchanges. Through the NPM Data and Intelligence database from Nasdaq Private Market, you can view Pulmocide share price and other valuable private market data.
Read more about secondary market private company stock prices:
There is no ticker symbol for Pulmocide stock because it is a private company. Private companies do not have ticker symbols like public companies, they are identified primarily by using the company ‘street’ name or legal name.
Nasdaq Private Market currently works with employees, ex-employees, and other company investors. In order to sell Pulmocide stock you need to receive the company’s approval, which Nasdaq Private Market manages on your behalf.
Learn more about selling privately held stock on the Employee Shareholders page.
Read more about how to sell shares of a private company and eligibility for selling privately held stock:
Currently, Nasdaq Private Market only works with accredited entities and institutional investors to purchase private company stock. In order to invest in Pulmocide stock, you need to be an accredited entity or institutional investor.
Learn more about the Nasdaq Private Market tool kit for investors on the Investor Trading page.
Once you buy or sell, stock share ownership must transfer before funds are wired. With Nasdaq Private Market, clients leverage our patent-pending Transfer and Settlement technology which streamlines and manages transfer activity from match to settlement.
To learn more about private company stock Transfer and Settlement, check out the Transfer and Settlement page.
Pulmocide is a private company and has not had an IPO. There is currently no Pulmocide IPO price. Get started to begin exploring the Nasdaq Private Market Data and Intelligence database and gain access to actionable data related to Pulmocide IPO.
Learn more about Data and Intelligence private company stock data for institutional investors on the on the NPM Data and Intelligence Product Page.
